Management of disease-related malnutrition for patients being treated in hospital.
Journal
Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R
Informations de publication
Date de publication:
20 11 2021
20 11 2021
Historique:
received:
14
04
2021
revised:
16
06
2021
accepted:
21
06
2021
pubmed:
18
10
2021
medline:
11
1
2022
entrez:
17
10
2021
Statut:
ppublish
Résumé
Disease-related malnutrition in adult patients who have been admitted to hospital is a syndrome associated with substantially increased morbidity, disability, short-term and long-term mortality, impaired recovery from illness, and cost of care. There is uncertainty regarding optimal diagnostic criteria, definitions for malnutrition, and how to identify patients who would benefit from nutritional intervention. Malnutrition has become the focus of research aimed at translating current knowledge of its pathophysiology into improved diagnosis and treatment. Researchers are particularly interested in developing nutritional interventions that reverse the negative effects of disease-related malnutrition in the hospital setting. High-quality randomised trials have provided evidence that nutritional therapy can reduce morbidity and other complications associated with malnutrition in some patients. Screening of patients for risk of malnutrition at hospital admission, followed by nutritional assessment and individualised nutritional interventions for malnourished patients, should become part of routine clinical care and multimodal treatment in hospitals worldwide.
Identifiants
pubmed: 34656286
pii: S0140-6736(21)01451-3
doi: 10.1016/S0140-6736(21)01451-3
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1927-1938Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests PS reports grants from the Swiss National Science Foundation (PP00P3_150531), the Research Committee of the Kantonsspital Aarau (1410.000.058 and 1410.000.044), Nestle Health Science, and Abbott Nutrition. ZS reports grants from Nestle Health Science, Abbott Nutrition, Fresenius Kabi, and B Braun.